ATE516021T1 - Verwendung von opioid-rezeptor-antagonisten - Google Patents

Verwendung von opioid-rezeptor-antagonisten

Info

Publication number
ATE516021T1
ATE516021T1 AT07724368T AT07724368T ATE516021T1 AT E516021 T1 ATE516021 T1 AT E516021T1 AT 07724368 T AT07724368 T AT 07724368T AT 07724368 T AT07724368 T AT 07724368T AT E516021 T1 ATE516021 T1 AT E516021T1
Authority
AT
Austria
Prior art keywords
receptor antagonists
opioid receptor
relates
hair
present
Prior art date
Application number
AT07724368T
Other languages
English (en)
Inventor
Raphael Beumer
Jochen Klock
Daniela Massa
Christine Mendrok-Edinger
Marcella Trembley
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE516021T1 publication Critical patent/ATE516021T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
AT07724368T 2006-04-21 2007-04-19 Verwendung von opioid-rezeptor-antagonisten ATE516021T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06008276 2006-04-21
PCT/EP2007/003431 WO2007121916A2 (en) 2006-04-21 2007-04-19 Use of opioid receptor antagonists

Publications (1)

Publication Number Publication Date
ATE516021T1 true ATE516021T1 (de) 2011-07-15

Family

ID=38254957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07724368T ATE516021T1 (de) 2006-04-21 2007-04-19 Verwendung von opioid-rezeptor-antagonisten

Country Status (7)

Country Link
US (1) US20090325857A1 (de)
EP (1) EP2034977B1 (de)
JP (1) JP5176188B2 (de)
KR (1) KR101453107B1 (de)
CN (1) CN101426481B (de)
AT (1) ATE516021T1 (de)
WO (1) WO2007121916A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580861B2 (en) * 2008-08-15 2013-11-12 Pibed Limited Chemical composition for skin care formulations
BR112013009505B1 (pt) 2010-10-19 2022-06-21 Memorial Sloan-Kettering Cancer Center Composto, composição farmacêutica, métodos para ensaio quanto a um receptor, e, usos de um composto
DE102011089226A1 (de) * 2011-12-20 2013-06-20 Henkel Ag & Co. Kgaa High-Care-Shampoo
US20150377751A1 (en) * 2013-08-01 2015-12-31 The Procter & Gamble Company Method of collecting and quantifying melanin in skin
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
EP4212532A3 (de) 2015-04-30 2023-09-27 Memorial Sloan Kettering Cancer Center Mitragynin-analoga und verwendungen davon
DE202015006894U1 (de) * 2015-08-31 2015-12-21 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Zusammensetzungen enthaltend einen Extrakt aus Echinacea und Linolsäurederivate
WO2024227190A1 (en) * 2023-04-28 2024-10-31 Arizona Board Of Regents On Behalf Of The University Of Arizona Druggable formulation for mu/delta opioid antagonist for enhancing pain therapy and treatment of opioid withdrawal

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE433323C (de) 1924-03-28 1926-09-24 Karl Werner Dipl Ing Zur Achse des Werkstuecks schraeg stehende Fraeserscheibe zur Herstellung schraubenfoermiger Profile
FR2110268B1 (de) 1970-10-07 1976-06-04 Minnesota Mining & Mfg
US4237253A (en) 1977-04-21 1980-12-02 L'oreal Copolymers, their process of preparation, and cosmetic compounds containing them
US4416886A (en) * 1981-07-29 1983-11-22 Dermall Limited Method of treating pruritis and composition therefor
AU8952282A (en) * 1982-08-25 1984-03-29 Joel E. Bernstein Method of treating pruritis and composition therefor
ZA856002B (en) * 1984-08-10 1987-04-29 Du Pont Transdermal delivery of opioids
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
JPS6245527A (ja) * 1985-08-21 1987-02-27 Shiseido Co Ltd 白髪予防、治療剤
JPS63183518A (ja) * 1986-09-18 1988-07-28 Lion Corp 毛髪用組成物
LU86703A1 (fr) 1986-12-08 1988-07-14 Oreal Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b
LU86715A1 (fr) * 1986-12-16 1988-07-14 Oreal Composition cosmetique contenant des derives hydroxyles de chalcone et son utilisation pour la protection de la peau et des cheveux contre les radiations lumineuses,nouveaux derives hydroxyles de chalcone utilises et leur procede de preparation
DE3708451A1 (de) 1987-03-16 1988-10-06 Henkel Kgaa Zwitterionische polymere und deren verwendung in haarbehandlungsmitteln
JPH0669940B2 (ja) * 1988-03-16 1994-09-07 ライオン株式会社 白髪防止剤
FR2636338B1 (fr) 1988-09-09 1990-11-23 Rhone Poulenc Chimie Diorganopolysiloxane a fonction benzalmalonate
JPH02142717A (ja) * 1988-11-22 1990-05-31 Kanebo Ltd 養毛化粧料
DE3929973A1 (de) 1989-09-08 1991-03-14 Henkel Kgaa Haarpflegemittel
FR2658075B1 (fr) 1990-02-14 1992-05-07 Oreal Composition cosmetique filtrante photostable contenant un filtre uv-a et un beta,beta-diphenylacrylate ou alpha-cyano-beta,beta-diphenylacrylate d'alkyle.
JP2937446B2 (ja) * 1990-09-14 1999-08-23 株式会社資生堂 白髪防止黒化剤
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US5270328A (en) 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
CZ284993B6 (cs) 1991-03-29 1999-04-14 Eli Lilly And Company Derivát piperidinu
GB9110123D0 (en) 1991-05-10 1991-07-03 Dow Corning Organosilicon compounds their preparation and use
JP3120086B2 (ja) * 1991-10-28 2000-12-25 倉敷紡績株式会社 白髪の防止及び白髪黒色化用毛髪化粧料
US6235496B1 (en) * 1993-03-08 2001-05-22 Advanced Research & Technology Institute Nucleic acid encoding mammalian mu opioid receptor
JPH06305940A (ja) * 1993-04-22 1994-11-01 Lion Corp 毛髪用組成物
US5434171A (en) 1993-12-08 1995-07-18 Eli Lilly And Company Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates
IL115558A (en) 1994-10-14 2000-01-31 Givaudan Roure Int Photostable cosmetic light-screening compositions comprising organosiloxane derivatives
FR2739281B1 (fr) 1995-09-29 1997-10-31 Oreal Composition topique contenant un polymere greffe silicone et une silicone aminee et/ou une gomme ou une resine siliconee
US6033649A (en) 1995-12-18 2000-03-07 Roche Vitamins Inc. Light screening agents
JPH1095716A (ja) * 1996-09-19 1998-04-14 Kao Corp 白髪防止剤
US6069170A (en) 1997-08-05 2000-05-30 Roche Vitamins Inc. Light screening compounds and compositions
JPH11315012A (ja) * 1998-03-04 1999-11-16 Shiseido Co Ltd サイクリックａｍｐ誘導剤
DE19917906A1 (de) 1999-04-20 2000-10-26 Basf Ag Verwendung von aminosubstituierten Hydroxybenzophenonen als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
EP1244447B1 (de) 1999-11-29 2007-01-10 Adolor Corporation Neue verfahren und zubereitungen die opioiden und deren antagonisten enthalten
AU4136901A (en) 1999-11-29 2001-06-18 Adolor Corporation Novel methods for the treatment and prevention of dizziness and pruritus
EP1244448B1 (de) 1999-11-29 2009-05-27 Adolor Corporation Neue methoden und verfahren zur behandlung und vermeidung von ileus
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
WO2002098422A1 (en) 2001-06-05 2002-12-12 University Of Chicago Use of methylnaltrexone to treat immune suppression
US6740641B2 (en) * 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain
GB0202853D0 (en) 2002-02-07 2002-03-27 Dow Corning Encapsulation process and encapsulated compositions
WO2003101963A1 (en) 2002-05-30 2003-12-11 Eli Lilly And Company Opioid receptor antagonists
DE10229842A1 (de) * 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
US6794510B2 (en) 2002-08-08 2004-09-21 Adolor Corporation Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto
EP1579212B1 (de) 2002-10-25 2008-12-31 MDS Analytical Technologies (US) Inc. Verfahren zur identifizierung von transmembranrezeptoragonisten mit reduzierter internalisierung
DE10256947A1 (de) 2002-12-05 2004-06-24 Grünenthal GmbH Verfahren zur Messung der Aktivität G(alpha)i- oder G(alpha)o-gekoppelter Rezeptoren mittels Ca2+-Influx in Zellen
AU2005215881B2 (en) 2004-02-13 2010-11-11 Dsm Ip Assets B.V. Ionic UV-A sunscreens and compositions containing them
JP2006028143A (ja) * 2004-07-21 2006-02-02 Shiseido Co Ltd Ｍｉｔｆ遺伝子発現促進物質
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
JP2009508895A (ja) * 2005-09-23 2009-03-05 ディーエスエム アイピー アセッツ ビー．ブイ． オピオイド受容体拮抗薬の使用

Also Published As

Publication number Publication date
EP2034977B1 (de) 2011-07-13
JP5176188B2 (ja) 2013-04-03
KR20080110822A (ko) 2008-12-19
JP2009534334A (ja) 2009-09-24
US20090325857A1 (en) 2009-12-31
KR101453107B1 (ko) 2014-10-27
WO2007121916A2 (en) 2007-11-01
EP2034977A2 (de) 2009-03-18
CN101426481A (zh) 2009-05-06
WO2007121916A3 (en) 2007-12-21
CN101426481B (zh) 2012-12-05

Similar Documents

Publication Publication Date Title
DE602007012072D1 (de) Orantagonisten
CL2011000976A1 (es) Compuestos derivados de isonicotinamida y carboxamida, antagonistas de los receptores de orexina; composicion farmaceutica que los comprende; y su uso para la prevencion de un trastorno del sueno.
WO2007121916A3 (en) Use of opioid receptor antagonists
BRPI0816934A2 (pt) Estimulador da musculatura facial e bucal
WO2013176897A3 (en) Composition for reduction of trpa1 and trpv1 sensations
IL185626A0 (en) Sublingual coated tablet
MX2009003645A (es) Azaciclilaminas n-sustituidas como antagonistas de histamina-3.
DK2238110T3 (da) 5.6-bisaryl-2-pyridin-carboxamid-derivater, fremstilling heraf og terapeutisk anvendelse heraf som urotensin II-receptorantagonister
PL1877390T3 (pl) Związki benzizoksazolopiperazynowe i sposoby ich stosowania
CY1114023T1 (el) Διυποκατεστημενης φθαλαζινης ανταγωνιστες σηματοδοτικης οδου hedgehog
WO2010144477A3 (en) Sulfonylurea modulators of endothelin receptor
ATE553082T1 (de) 5,6-bisaryl-2-pyridin-carboxamid-derivate sowie ihre herstellung und anwendung in therapeutika als urotensin-ii-rezeptor-antagonisten
NO20092073L (no) Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav
WO2011060363A3 (en) Cyclohexyl urea modulators of d2 receptors and/or d3 receptors
PH12012501522A1 (en) Oral care compositions
MX2012010714A (es) Antagonistas de ccr3 de arilsulfonamida.
ATE466854T1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
ATE450256T1 (de) Verwendung von zusammensetzungen enthaltend kappa-opioidrezeptor-antagonisten zur behandlung von dissoziativen störungen
CO6501122A2 (es) Nuevos derivados de (heterociclo-piperidina condensada) - (piperazinil)-1-alcanona o de (heterocilco-pirrolidina condensada)-(pieprazinil)-1-alcanona y su utilizacion como inhibidores de p75
CL2011002893A1 (es) Peptido derivado del factor viii; composicion que lo comprende; uso para aumentar la tolerancia a factor viii en individuos que padecen o estan en riesgo de padecer hemofilia a o hemofilia adquirida.
MA32321B1 (fr) Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers
WO2010123956A3 (en) 2,5-disubstituted arylsulfonamide ccr3 antagonists
HRP20080617T3 (en) Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin
DE602006004964D1 (de) Dihydrochinazolinone als 5ht-modulatoren
NO20064053L (no) Androgen reseptormodulatorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties